FSD Pharma announced today that its wholly-owned subsidiary FV Pharma has received its Sale for Medical Purposes license to sell cannabis under the Cannabis Act (Canada). The license went into effect on April 18, 2019.
"The license allows the current FSD facility to supply and sell cannabis products. We anticipate receiving the amended sales license that will include the sale of dried and fresh cannabis flower in the near future," the company explains.
Dr. Raza Bokhari, Executive Co-Chairman and CEO congratulated the FSD Pharma team, shareholders and stakeholders on this much anticipated achievement. Dr. Bokhari states, “Our sales license is a key development for FSD Pharma and a step forward for our Cobourg Facility.”
Zeeshan Saeed, President and Founder, added, “The granting of our sales license allows FSD to serve the growing medicinal use markets in Canada. We intend to quickly scale up production at our current facility, while continuing to build out the plant to add additional grow capacity."